Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...

Aaron Ciechanover (2004, Chemistry) delivered a special address at the inaugural of ProUPS (Proteostasis & Ubiquitin Proteasome System) conference held at SRM Institute of Science and Technology ...

Q4 2024 Earnings Call Transcript February 13, 2025 Blueprint Medicines Corporation misses on earnings expectations. Reported ...

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...

Shareholder distributions are appropriate. Capital intensity of the industry remains low and gross margins high. In addition, Cochlear enjoys high cash conversion, enabling it to typically pay out 70% ...

Patients Achieved Remission Within 30 Days in Cohort 1 of the Mipletamig RAINIER Dose Optimization Trial for Frontline AML Patients, Trial Enrollment ContinuesPromising Data, including a 59% Stable ...

Zydus and Synthon ink exclusive development, licensing & commercialization agreement for a novel 505(B)(2) oncology product for US market: Our Bureau, Mumbai Friday, February 14, ...

At this time, I would like to welcome everyone to the DaVita fourth-quarter 2024 earnings call. (Operator Instructions) Mr. Eliason, you may begin. Thank you and welcome to our fourth quarter ...

Fiserv, Inc. , a leading global provider of payments and financial services technology, today announced it will deliver digital innovation through the award-winning DNA® platform to Third Federal ...

Blueprint Medicines Corporation BPMC reported fourth-quarter 2024 adjusted loss of 79 cents per share, wider than the Zacks ...